4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000046
Chief Scientific Officer sold 17,878 shares at an average $18.03 ($322,389)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sethuraman Natarajan Chief Scientific Officer | 2023-07-10 | Sale 10b5-1 | −3,026 | $18.00 | $54,474 | 168,299 | D |
| Sethuraman Natarajan Chief Scientific Officer | 2023-07-11 | Sale 10b5-1 | −14,852 | $18.04 | $267,915 | 153,447 | D |
| Open-market sales · 17,878 sh · avg $18.03 · $322,389 | |||||||
Loading xslF345X04/wf-form4_168919391527267.xml…